Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrastromal Moxifloxacin in Recalcitrant Bacterial Keratitis
NCT07394257Recruiting
- Sponsor
- Minia University
- Start
- Oct 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Moxisurge in bacterial keratitis (2 arms), sponsored by Minia University. Primary endpoint: Time to complete clinical resolution. Started Oct 2025; status: recruiting.
02
Drugs
Moxisurge
03
Conditions
bacterial keratitis
Beyond the preview
Go deeper on NCT07394257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07394257.